Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Payables (2016 - 2025)

AC Immune (ACIU) has disclosed Payables for 10 consecutive years, with $2.6 million as the latest value for Q4 2025.

  • Quarterly Payables fell 14.72% to $2.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.6 million through Dec 2025, down 14.72% year-over-year, with the annual reading at $2.6 million for FY2025, 14.72% down from the prior year.
  • Payables for Q4 2025 was $2.6 million at AC Immune, down from $3.0 million in the prior quarter.
  • The five-year high for Payables was $3.0 million in Q4 2024, with the low at $964322.4 in Q4 2022.
  • Average Payables over 5 years is $2.1 million, with a median of $2.2 million recorded in 2021.
  • The sharpest move saw Payables crashed 55.61% in 2022, then surged 96.29% in 2023.
  • Over 5 years, Payables stood at $2.2 million in 2021, then plummeted by 55.61% to $964322.4 in 2022, then soared by 96.29% to $1.9 million in 2023, then soared by 60.3% to $3.0 million in 2024, then decreased by 14.72% to $2.6 million in 2025.
  • According to Business Quant data, Payables over the past three periods came in at $2.6 million, $3.0 million, and $1.9 million for Q4 2025, Q4 2024, and Q4 2023 respectively.